Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Nucleoside analogues reduce hepatitis B liver cancer risk

Treatment of chronic hepatitis B with nucleoside analogues including lamivudine (Epivir) and entecavir (Baraclude) can reduce the risk of developing hepatocellular carcinoma, including cancer recurrence after successful resection

Published
29 November 2012
By
Liz Highleyman
European Commission approves Viread ® for HIV-1 infection in children and adolescents and for chronic hepatitis B in adolescents

New oral granule formulation and lower-strength tablets available for new indications.

Published
28 November 2012
From
Gilead press release
Copy of European Commission approves Viread ® for HIV-1 infection in children and adolescents and for chronic hepatitis B in adolescents

New oral granule formulation and lower-strength tablets available for new indications.

Published
28 November 2012
From
Gilead press release
Hepatitis C Reaching Crisis Levels; Requires Coverage for Routine Screenings

As the countdown to implementation of the Affordable Care Act begins in earnest, experts on the front lines in fighting viral hepatitis and HIV/AIDS issued this harsh assessment regarding escalating levels of hepatitis C virus (HCV) infection: unless policymakers require insurers to cover the costs of screening everyone at potential risk for HCV, rates of cirrhosis and liver cancer will continue to rise and become a major drain on the healthcare system.

Published
28 November 2012
From
National Summit on HIV and Viral Hepatitis press release
Gilead Announces Sustained Virologic Response Rate of 78% From Phase 3 Study of Sofosbuvir for Genotype 2/3 Hepatitis C Infected Patients

POSITRON Demonstrates Efficacy of a 12-Week All-Oral Regimen of Sofosbuvir Plus Ribavirin for Chronic Hepatitis C Patients who are Unable or Unwilling to Take Interferon

Published
27 November 2012
From
Gilead press release
Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

The U.S. Preventive Services Task Force (USPSTF) recommends screening for hepatitis C virus (HCV) infection in adults at high risk, including those with any history of intravenous drug use or blood transfusions prior to 1992 (see the Clinical Considerations for more information on risk factors). This is a grade B recommendation.

Published
27 November 2012
From
US Preventive Services Task Force
Less Support for Hepatitis C Testing for Baby Boomers

An influential advisory committee has given only lukewarm support to a government recommendation that all baby boomers be tested for hepatitis C.

Published
27 November 2012
From
New York Times
Screening for Hepatitis C Virus Infection in Adults: A Systematic Review

A Systematic Review to Update the 2004 U.S. Preventive Services Task Force Recommendation.

Published
27 November 2012
From
US Preventive Services Task Force
HCV Screening Benefit Still Uncertain

The value of screening for hepatitis C remains an open question, according to three analyses intended to form the basis for new recommendations on the topic.

Published
27 November 2012
From
MedPage Today
Sharing drug preparation equipment a potential source of hepatitis C transmission

Drug users who share injecting equipment such as water, filters and water containers are potentially putting themselves at risk of infection with hepatitis C virus (HCV), according

Published
27 November 2012
By
Michael Carter

Filter by country